caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1922069624

Alex NguyenM. D.

Hematology-OncologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Alex Nguyen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
116976
Stephen Parven
Diagnostic Radiology · Houston, TX
2872
METHODIST HEALTH CENTERS27150
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
22109
Nowice Trexler
Diagnostic Radiology · Houston, TX
2265
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
2058
Tse-Kuan Yu
Radiation Oncology · Houston, TX
17521
Su Chang
Cardiology · Houston, TX
1356
City Of Houston
Ambulance Service Provider · Houston, TX
1218
Stanley Lim
Diagnostic Radiology · Houston, TX
1124
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,776
Unique beneficiaries
—
Total services
115,671
Distinct HCPCS
35
Medicare payment
$363K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — top quintile (cohort median 2,625).
PRESCRIBING · PART D · 2024
Total Rx claims
2,055
Beneficiaries
—
Total drug cost
$7.8M
Distinct drugs
52
Brand share
49.0%
Top prescribed drugs
Famciclovir118 claims
Hydroxyurea106 claims
Sulfamethoxazole/Trimethoprim95 claims
Dexamethasone92 claims
Aprepitant89 claims
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
71.8
Cost
66.8
Improvement activities
40.0
Promoting interop.
97.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
132
By payment type
Food and Beverage$3K
Education$101